Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 96M | 119M | 105M | 104M | 119M | 120M |
| Cost of revenue | 61M | 68M | 67M | 63M | 83M | 71M |
| Gross profit | 35M | 51M | 38M | 41M | 35M | 49M |
| Research and development | 2M | 2M | 2M | 2M | 3M | 4M |
| Selling, general and administrative | 18M | 15M | 15M | 14M | 17M | 18M |
| Operating expenses | 52M | 63M | 52M | 56M | 82M | 63M |
| Operating income | −17M | −12M | −14M | −14M | −47M | −15M |
| Pre-tax income | −31M | −12M | −17M | −19M | −39M | 45,000 |
| Income tax | 47,000 | 53,000 | 54,000 | 41,000 | 63,000 | 54,000 |
| Net income | −31M | −12M | −17M | −19M | −39M | −9,000 |
| Earnings per share | −0.28 | 0.11 | 0.16 | 0.18 | 0.36 | 0.00 |
| Earnings per share, diluted | −0.28 | 0.11 | 0.16 | 0.18 | 0.36 | 0.00 |
| Weighted average shares | 108M | 108M | 108M | 108M | 108M | 107M |
| Weighted average shares, diluted | 108M | 108M | 108M | 108M | 108M | 108M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 25M | 24M | 32M | 34M | 22M | 29M | 23M | 23M |
| Receivables | 21M | 41M | 25M |
| Metric | 31 Mar 2026 | 30 Jun 2025 | 31 Mar 2025 | 30 Jun 2024 |
|---|---|---|---|---|
| Operating cash flow | 3M | — | −23M | — |
| Depreciation and amortisation | 4M | — | 5M | — |
| Share-based compensation | 156,000 | 477,000 | 368,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 21M |
| 24M |
| 33M |
| 30M |
| 32M |
| Inventory | 58M | 60M | 66M | 61M | 60M | 57M | 60M | 70M |
| Current assets | 116M | 137M | 136M | 126M | 113M | 126M | 123M | 131M |
| Property, plant and equipment | 76M | 78M | 79M | 87M | 90M | 94M | 100M | 119M |
| Total assets | 272M | 296M | 302M | 304M | 294M | 308M | 309M | 362M |
| Current liabilities | 93M | 102M | 97M | 84M | 84M | 101M | 94M | 92M |
| Total liabilities | 332M | 326M | 329M | 319M | 292M | 288M | 281M | 296M |
| Equity | −60M | −30M | −27M | −16M | 1M | 20M | 28M | 67M |
| 825,000 |
| Capital expenditure | 2M | — | 2M | — |
| Investing cash flow | −2M | — | −2M | — |
| Financing cash flow | −346,000 | — | 18M | — |